How do you pay?

How to pay the least

Ask for the cash price

Vyalev

We didn’t find one.

  1. Ask your pharmacy for Vyalev’s cash price, and one or two other pharmacies too.
  2. Vyalev’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify myAbbVie Assist. Our income guidelines are based on the size of your household and annual income. Or call 1-800-222-6885.

See if you qualify 

Compare every option

Question
Brand nameVyalev
Authorized genericfoscarbidopa and foslevodopa
Regular genericfoscarbidopa and foslevodopa
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Vyalev?
The original
–
–

Brand nameThe maker’s card

VYALEV® Savings Program (VYALEV Complete)

Savings card from AbbVie

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $16,500 a year off your co-pay.

Sign up on vyalev.com 

Or call 1-866-489-2538.

In the maker’s words

“Eligible commercially insured patients may pay as little as $0 per monthly prescription fill.”

From the maker’s offer on vyalev.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Vyalev itself, from the same company, sold without the brand name, and usually for less. For now Vyalev is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VYALEV is a combination of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease.

Source: the FDA label for Vyalev (AbbVie Inc.), March 19, 2026. Full label on DailyMed 

Good to know